We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is likely to update an 8-year-old draft guidance on weight loss drugs to address newer long-term therapies and to advance an HHS campaign to alleviate the obesity epidemic in the U.S., the agency said on Friday.